- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Ritholtz Wealth Management Boosts Stake in Bristol Myers Squibb
Firm increases position in pharmaceutical company by over 200%
Apr. 12, 2026 at 10:05am
Got story updates? Submit your updates here. ›
Ritholtz Wealth Management's increased investment in Bristol Myers Squibb reflects the firm's confidence in the pharmaceutical company's long-term growth potential.Princeton TodayRitholtz Wealth Management, a leading investment management firm, has significantly increased its stake in Bristol Myers Squibb Company (NYSE: BMY), a major biopharmaceutical company. According to a recent SEC filing, Ritholtz Wealth Management boosted its position in Bristol Myers Squibb by 214.2% in the fourth quarter, now owning 62,577 shares of the company's stock.
Why it matters
This move by Ritholtz Wealth Management, a respected investment firm, suggests increased confidence in Bristol Myers Squibb's prospects and growth potential. The pharmaceutical industry has been a focus area for many investors given the ongoing developments in the healthcare sector.
The details
Ritholtz Wealth Management's increased stake in Bristol Myers Squibb was part of a broader strategy to bolster its position in the biopharmaceutical company. The firm purchased an additional 42,658 shares during the fourth quarter, bringing its total holdings to 62,577 shares valued at $3,375,000 at the end of the reporting period.
- Ritholtz Wealth Management increased its position in Bristol Myers Squibb in the 4th quarter of 2026.
The players
Ritholtz Wealth Management
A leading investment management firm that has significantly increased its stake in Bristol Myers Squibb Company.
Bristol Myers Squibb Company
A major biopharmaceutical company that Ritholtz Wealth Management has increased its investment in.
The takeaway
Ritholtz Wealth Management's substantial increase in its Bristol Myers Squibb holdings suggests the firm sees strong growth potential in the pharmaceutical company, which could signal positive developments for the broader industry.
